Complementary Actions All Around: Lowering Cardiometabolic Risks While Achieving Glycemic Targets with GLP-1 RAs

All Live and On-Demand Activities

Filter Activities

Clear

Episode 2 of 3: Overcoming Barriers to Prescribing: A Med Table Talk™: Targeted Therapy in Atopic Dermatitis Series

.75 hr(s) | CME

Specialty: Atopic Dermatitis

Therapeutic Area(s): Allergy , Dermatology

Release Date: April 29, 2022

Expiration Date: September 1, 2023

Location: Internet Enduring Activity

In episode 2 of the 3-part educational initiative TRANSFORMING TARGETED THERAPY IN ATOPIC DERMATITIS: APPLYING EMERGING DATA AND EVOLVING BEST PRACTICES TO IMPROVE OUTCOMES, dermatologists and allergists discuss overcoming barriers to the use of oral JAK inhibitors. This activity focuses on the mechanistic rationale for the benefit and risk profiles of oral JAK inhibitors, how to address the black box warnings, and making treatment decisions based on patients’ values and goals.

Expanding the Benefits and Refining the Role of Immune Checkpoint Inhibitors in the Treatment of Recurrent and Advanced Endometrial Cancer

0.50 hr(s) | ABIM , CME , MOC , NCPD

Specialty: Endometrial Cancer , Gynecologic Cancer , Oncology

Therapeutic Area(s): Endometrial Cancer , Gynecology , Oncology

Release Date: April 27, 2022

Expiration Date: April 26, 2023

Location: Internet Enduring Activity

In this activity, an expert in oncology discusses the role of immune checkpoint inhibitors in the care of patients with recurrent and advanced endometrial cancer.

Episode 1 of 3: What You Need to Know About New Targeted Therapies for AD

0.75 hr(s) | CME

Specialty: Atopic Dermatitis

Therapeutic Area(s): Allergy , Dermatology

Release Date: April 22, 2022

Expiration Date: September 1, 2023

Location: Internet Enduring Activity

In episode 1 of the 3-part educational initiative TRANSFORMING TARGETED THERAPY IN ATOPIC DERMATITIS: APPLYING EMERGING DATA AND EVOLVING BEST PRACTICES TO IMPROVE OUTCOMES, dermatologists and allergists discuss what practicing clinicians need to know about newly approved oral JAK inhibitors. This activity focuses on the mechanism of action of novel targeted agents, their key safety and efficacy data, and their role in the treatment paradigm for atopic dermatitis.

Modern Management of ITP: Thinking Beyond the Conventional Therapies

0.50 hr(s) | CME

Therapeutic Area(s): Hematology , Oncology

Release Date: March 8, 2022

Expiration Date: March 7, 2023

Location: Internet Enduring Activity

In this animated, visually-enhanced activity, an expert in hematology-oncology discusses current standards for diagnosing and treating idiopathic thrombocytopenic purpura—and provides an update on the challenges associated with modern care and the promise of novel therapeutic options for disease management.

How I Think, How I Treat - Assessing, Managing and Engaging Patients with Uncontrolled Moderate-to-Severe Asthma: Comparing Approaches with Experts Around the World

hr(s) | CME

Specialty: Asthma

Therapeutic Area(s): Allergy , Immunology , Pulmonology

Release Date: April 12, 2022

Expiration Date: April 11, 2023

Location: Internet Enduring Activity

In this activity, experts in asthma discuss assessing and managing uncontrolled, moderate to severe asthma for pediatric and adult patients, as well as selecting targeted therapies and improving treatment adherence.

Applying Evidence to Practice in Postpartum Depression: Expert Guidance on Integrating Therapeutic Innovations and Shared Decision-Making Strategies to Optimize Patient Care

1.00 hr(s) | CME

Therapeutic Area(s): Gynecology , Women's Health

Release Date: April 8, 2022

Expiration Date: April 7, 2023

Location: Internet Enduring Activity

In this activity, an expert in women’s behavioral health shares a downloadable tool kit created for OB/GYNs and other clinicians to facilitate the screening, diagnosis, and treatment of postpartum depression (PPD) and to provide guidance on the use of shared decision-making strategies to optimize patient care.

Solving the Challenge of Tumor Lysis Syndrome: Expert Insight and Guidance on a Challenging Oncologic Emergency

0.50 hr(s) | ABIM , CME , MOC , NCPD , Royal College of Physicians and Surgeons of Canada

Specialty: Tumor Lysis Syndrome

Therapeutic Area(s): Hematology

Release Date: April 4, 2022

Expiration Date: April 3, 2023

Location: Internet Enduring Activity

Tumor lysis syndrome (TLS) is a serious and potentially fatal oncologic emergency that, paradoxically, is partially linked to the use of highly effective anticancer treatment. How can the management team rise to the challenge of TLS? In this activity, Anthony R. Mato, MD, MSCE, and Kristen Battiato, MSN, RN, AGNP-C, will provide an answer. Join them as they explore team-based management of TLS and provide guidance on developing TLS management plans. Throughout this program, the experts will use real-world case scenarios to demonstrate how professionals can work together to identify risk factors for TLS, recognize its laboratory and clinical symptoms, and prevent its occurrence.

Episode 4 of 4 of the series on: The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes

0.50 hr(s) | Case Managers , CME , NCPD , Physician Assistants

Specialty: B-cell Malignancies , Lymphoma

Therapeutic Area(s): CAR T , Hematology, Malignant

Release Date: April 8, 2022

Expiration Date: April 8, 2023

Location: Internet Enduring Activity

Opening the CAR(T) Door to Get Patient to Therapy, episode 4 of the 4-part educational initiative The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes, is designed for community-based oncology clinicians. This CE activity includes conversations among CAR-T experts and a community clinician; it includes patient video clips and numerous downloadable resources including a directory of CAR-T treatment centers organized by state. This activity focuses on managing logistics associated with CAR-T therapy, including common misperceptions, the numerous services offered by treating centers, and how to overcome roadblocks for your patients.

Complementary Actions All Around: Lowering Cardiometabolic Risks While Achieving Glycemic Targets with GLP-1 RAs

0.50 hr(s) | CME

Specialty: Diabetes

Therapeutic Area(s): Endocrinology

Release Date: March 25, 2022

Expiration Date: March 24, 2023

Location: Internet Enduring Activity

How much do you really know about GLP-1 RAs in the management of T2DM? Test your knowledge about guideline recommendations, current evidence, and strategies to individualize treatment for patients with T2DM using GLP-1 RAs with realistic case-based scenarios. If you need a little help navigating a clinical scenario, a leading endocrinologist will examine current recommendations and evidence for GLP-1 RAs in the management of T2DM, as well as offer his insights on individualizing treatment plans to help patients reach their goals and reduce cardiovascular risks. Think you have all the answers? If so, you’ll be able to take the post-test and claim credit quickly!

1 2 3 7
Copy link
Powered by Social Snap